norm: oncotelic therapeuticsNAICS 325412 · USno LEI · CIK 0000908259Max severity: Low

Canonical registry

Oncotelic Therapeutics, Inc.

ent_019e3eb87b38a038f54d2a55cd213d6f

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Multi-filing incidents

—

no multi-filing incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Oncotelic Therapeutics, Inc.
Normalized: oncotelic therapeutics— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0000908259
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2026-04-15
This is a 10-K Item 1C cybersecurity risk management disclosure from an unidentified SEC registrant. The filing describes planned (not yet implemented) cybersecurity controls and governance structures. The company explicitly states it has not encountered cybersecurity challenges that have materially impaired its operations or financial standing. No breach incident is described.